Burden of laboratory-confirmed Campylobacter infections in Guatemala 2008-2012: Results from a facility-based surveillance system

Journal of Epidemiology and Global Health

Volumn 4, Issue 1, 2014, Pages 51-59

  Benoit, Stephen R ^a   Lopez, Beatriz ^b   Arvelo, Wences ^a   Henao, Olga ^c   Parsons, Michele B ^c   Reyes, Lissette ^d   Moir, Juan Carlos ^d   Lindblade, Kim ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSIDAD DEL VALLE DE GUATEMALA   (Guatemala)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Ministry of Public Health and Social Assistance   (Guatemala)

Author keywords

Antimicrobial resistance; Campylobacter; Epidemiology; Guatemala

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; METRONIDAZOLE; NALIDIXIC ACID; TETRACYCLINE; ANTIINFECTIVE AGENT; ORAL REHYDRATION SOLUTION;

ACUTE DIARRHEA; ADULT; AMBULATORY CARE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL LOAD; BACTERIUM CULTURE; BACTERIUM ISOLATE; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CHILD; DISEASE SURVEILLANCE; FECES ANALYSIS; FEMALE; GUATEMALA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; ORAL REHYDRATION THERAPY; PRESCRIPTION; PRIORITY JOURNAL; TREND STUDY; ADOLESCENT; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CLINICAL TRIAL; COMPLICATION; COST OF ILLNESS; DIARRHEA; FECES; FLUID THERAPY; INFANT; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; PROCEDURES; SENTINEL SURVEILLANCE; YOUNG ADULT;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER; CAMPYLOBACTER INFECTIONS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; COMMUNICABLE DISEASE CONTROL; COST OF ILLNESS; DIARRHEA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FECES; FEMALE; FLUID THERAPY; GUATEMALA; HUMANS; INFANT; INFANT, NEWBORN; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; REHYDRATION SOLUTIONS; SENTINEL SURVEILLANCE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 84893981410     PISSN: 22106006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jegh.2013.10.001     Document Type: Article

References (27)

1. Allos B.M. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis 2001, 32(8):1201-1206.
2. Blaser M.J. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis 1997, 176(Suppl 2):S103-S105.
3. Allos B.M. Association between Campylobacter infection and Guillain-Barré syndrome. J Infect Dis 1997, 176(Suppl 2):S125-S128.
4. Halvorson H.A., Schlett C.D., Riddle M.S. Postinfectious irritable bowel syndrome-a meta-analysis. Am J Gastroenterol 2006, 101(8):1894-1899.
5. DuPont A.W. Postinfectious irritable bowel syndrome. Clin Infect Dis 2008, 46(4):594-599.
6. Kirkpatrick B.D., Tribble D.R. Update on human Campylobacter jejuni infections. Curr Opin Gastroenterol 2011, 27(1):1-7.
7. Smith J.L., Fratamico P.M. Fluoroquinolone resistance in Campylobacter. J Food Prot 2010, 73(6):1141-1152.
8. Payot S., Bolla J.M., Corcoran D., Fanning S., Mégraud F., Zhang Q. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect 2006, 8(7):1967-1971.
9. Pan American Health Organization (PAHO). Available at: Accessed on June 15, 2013. http://www1.paho.org/english/dd/ais/cp_320.htm.
10. Jensen L.A., Marlin J.W., Dyck D.D., Laubach H.E. Prevalence of multi-gastrointestinal infections with helminth, protozoan and Campylobacter spp. in Guatemalan children. J Infect Dev Ctries 2009, 3(3):229-234.
11. Cruz J.R., Cano F., Bartlett A.V., Méndez H. Infection, diarrhea, and dysentery caused by Shigella species and Campylobacter jejuni among Guatemalan rural children. Pediatr Infect Dis J 1994, 13(3):216-223.
12. Hurd S., Patrick M., Hatch J., Clogher P., Wymore K., Cronquist A.B., et al. Clinical Laboratory Practices for the isolation and identification of campylobacter in foodborne diseases active surveillance network (FoodNet) Sites: baseline information for understanding changes in surveillance data. Clin Infect Dis 2012, 54(Suppl 5):S440-S445.
13. Instituto Nacional de Estadistica. Available at: [accessed on June 20.06.12]. http://www.ine.gob.gt/np/poblacion/index.htm.
14. Reyes L., Arvelo W., Estevez A., Gray J., Moir J.C., Gordillo B., et al. Population-based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009. Influenza Other Respi Viruses 2010, 4(3):129-140.
15. Gilligan P.H., Whittier S. Reagents. Manual of clinical microbiology 1999, 526-538. ASM Press, Washington, D.C. 7th ed. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
16. Clinical and Laboratory Standards Institute (CLSI). Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved guideline-Second edition. CLSI-document M45-A2. (Wayne, PA.). 2010.
17. Centers for Disease Control and Prevention (CDC).National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, Atlanta 2010, U.S. Department of Health and Human Services, CDC, Georgia, 2012.
18. Lehtopolku M., Nakari U.M., Kotilainen P., Huovinen P., Siitonen A., Hakanen A.J. Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrob Agents Chemother 2010, 54(3):1232-1236.
19. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 states, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(14):418-422.
20. Centers for Disease Control and Prevention (CDC). Vital signs: incidence and trends of infection with pathogens transmitted commonly through food-foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010. MMWR Morb Mortal Wkly Rep 2011, 60(22):749-755.
21. Baker M.G., Sneyd E., Wilson N.A. Is the major increase in notified campylobacteriosis in New Zealand real?. Epidemiol Infect 2007, 135(1):163-170.
22. OzFoodNet Working Group Burden and causes of food-borne disease in Australia: annual report of the OzFoodNet network, 2005. Commun Dis Intell 2006, 30:278-300.
23. European Centre for Disease Prevention and Control. Annual epidemiological report on communicable disease in Europe, 2010. Available at:[accessed on 25.09.12]. http://ecdc.europa.eu/en/publications/Publications/1011_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf.
24. Galanis E. Campylobacter and bacterial gastroenteritis. CMAJ 2007, 177(6):570-571.
25. Streit J.M., Jones R.N., Toleman M.A., Stratchounski L.S., Fritsche T.R. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003). Int J Antimicrob Agents 2006, 27(5):367-375.
26. Ailes E., Demma L., Hurd S., Hatch J., Jones T.F., Vugia D., et al. Continued decline in the incidence of Campylobacter infections, FoodNet 1996-2006. Foodborne Pathog Dis 2008, 5(3):329-337.
27. Lake I.R., Gillespie I.A., Bentham G., Nichols G.L., Lane C., Adak G.K., et al. A re-evaluation of the impact of temperature and climate change on foodborne illness. Epidemiol Infect 2009, 137(11):1538-1547.